Would EU Liability Proposal Boost EU Medtech Firms At Expense Of Non-EU Players?
This article was originally published in SRA
Executive Summary
As a ploy designed to tilt the balance of power to manufacturers based in the EU and discourage their non-EU rivals from entering this market, the Council of the European Union's proposal to make authorized representatives liable for defective devices manufactured by non-EU companies might be very effective.
You may also be interested in...
EU Experts Want One-Stop-Shop EU Governance That Mimics Best Of Other Jurisdictions
It may be blue sky thinking to surmise how a new EU medtech regulatory governance structure could evolve. But with change on the horizon, experts see exciting opportunities.
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
EU Regulatory Experts Support Notified Bodies, But Argue For Greater Consistency
Notified bodies have been a pivotal part of the EU medtech regulatory system since it was first launched in the 1990s. Where might they fit within a new medtech regulatory governance structure? Panelists on a recent vodcast grappled with the question.